IP Library › Granted Patent US 8,597,644
Granted Patent B2
US 8,597,644 · App. 11/947,267 · Granted Dec 3, 2013

Method for treating psoriasis by administering an antibody to interleukin-6 receptor

Inventors: Hiroaki Ito (Ashiya, JP); Kazuyuki Yoshizaki (Ashiya, JP); Norihiro Nishimoto (Minoh, JP); Tadamitsu Kishimoto (Tondabayashi, JP); Shin Shimaoka (Gotenba, JP); Hidetomo Kitamura (Gotenba, JP); Masamichi Sugimoto (Gotenba, JP); Kenichi Akamatsu (Gotenba, JP)
Assignee: Chugai Seiyaku Kabushiki Kaisha
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,597,644
App. No.
11/947,267
Granted
Dec 3, 2013
Kind
B2
Abstract

A method for treating psoriasis comprising an interleukin-6 (IL-6) antagonist such as, for example, an antibody against IL-6 receptor.

Claims (6)

1. A method for treating psoriasis comprising administering an effective amount of an antibody against interleukin-6 (IL-6) receptor to a subject in need thereof, wherein said antibody blocks binding between IL-6 and IL-6 receptor, and blocks signal transduction by IL-6.

2. The method of claim 1 , wherein IL-6 receptor is a human IL-6 receptor.

3. The method of claim 1 , wherein the antibody is a monoclonal antibody.

4. The method of claim 1 , wherein the antibody is a recombinant antibody.

5. The method of claim 1 , wherein the antibody is a humanized antibody.

6. The method of claim 1 , wherein the antibody is a human antibody.

Priority Claims (1)
JP 2000-325904 · Oct 25, 2000 · national
Continuity (2)
Division 10399979
Related Publication 20080124325A1 · May 29, 2008